National Menstrual Migraine Coalition Continuing Education Activitites (disclaimer)

Healthcare professionals interested in the diagnosis and management of headache are invited to complete these web-based activities.

These activities have been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Jefferson Medical College and IMED Communications. Jefferson Medical College of Thomas Jefferson University is accredited by the ACCME to provide continuing medal education for physicians.

These activities are supported by an educational grant from Endo Pharmaceuticals, Inc.

Instructions:
To receive CME/CE credit for your participation in this educational activity, you must complete both the post-test and the evaluation form. The participant should, in order, review the objectives listed for each activity to determine if the content relates to your individual learning needs, read the material carefully, paying particular attention to the tables and other illustrative materials, answer the multiple-choice post-test, and complete the evaluation form. Evaluation of this activity is integral to the CME/CE process. CME/CE certificates requests cannot be processed if the evaluation portion is not complete. CME/CE Certificates are printed on Friday of each week once an 80% or better post-test score and completed evaluation is confirmed. You will receive your certificate in the mail within 7-10 days. Earned credits are posted to the JeffETC website each Friday. (Please note that you must have a Web-ID to access the JeffETC system. Visit http://jeffline.jefferson.edu/jeffcme/JeffETC/ for more information) Requests for credit must be completed before the expiration date indicated for each activity. No credit will be given after that date.

If you any questions regarding the scoring of the post-test, the evaluation process or how to receive your Certificate and credits, please contact the office of CME at 1-800-Jeff CME or (215) 955-6992.

Elizabeth Battaglino Cahill, RN, MPA, has no relevant financial relationships to disclose.

Roger K. Cady, MD, has received grant/research support from Allergan; GlaxoSmithKline; Merck; Novartis; Ortho-McNeil; and is a scientific advisor for Allergan; Endo; GlaxoSmithKline; Merck; Novartis; Ortho-McNeil.

Judith S. Dempster, DNSc, FNP, FAANP, has no relevant financial relationships to disclose. Joan R. Golub, MD, is a consultant for Endo.

Susan L. Hutchinson, MD, has received grant/research support from GlaxoSmithKline; is a consultant for Endo; Forest Pharmaceuticals; GlaxoSmithKline; Merck; Ortho-McNeil; is a scientific advisor for GlaxoSmithKline; Ortho-McNeil; and is on the product/speaker’s bureau for Endo; Forest Pharmaceuticals; GlaxoSmithKline; Merck; Ortho-McNeil; Pfizer.

Vincent T. Martin, MD, has received grant/research support from Allergan; GlaxoSmithKline; is a consultant for Endo; Merck; and is on the product/speaker’s bureaus for Endo; GlaxoSmithKline; Pfizer.

Thomas J. Morrow, MD, has no relevant financial relationships to disclose.

Lawrence C. Newman, MD, has received grant/research support from Allergan; Endo; GlaxoSmithKline; Pfizer; is a consultant for Allergan; Endo; GlaxoSmithKline; Merck; Pfizer; is a scientific advisor for Endo; GlaxoSmithKline; and is on the product/speaker’s bureaus for Endo; GlaxoSmithKline; Merck; Pfizer.

L. Jo Parrish, MA, MBA, has no relevant financial relationships to disclose.

Fred D. Sheftell, MD, has received grant/research support from Allergan; Endo; GlaxoSmithKline; Ortho-McNeil; Pfizer; is a consultant for Endo; GlaxoSmithKline; Merck; Ortho-McNeil; is a scientific advisor for Endo; GlaxoSmithKline; Merck; Ortho McNeil; and is on the product/speaker’s bureaus for Endo; GlaxoSmithKline; Merck; Ortho McNeil.

Lee P. Shulman, MD, is a consultant for Berlex; Organon; Ortho-McNeil; and is on the product/speaker’s bureaus for Berlex; Organon; Ortho-McNeil; Wyeth.

Stephen D. Silberstein, MD, has received grant/research support from Abbott; Allergan; AstraZeneca; Eli Lilly; GlaxoSmithKline; Johnson & Johnson; Medtronics; Merck; NPS; Pfizer; Pozen; UCB Pharma; X-Cel Pharmaceuticals; is a consultant for Abbott; Allergan; AstraZeneca; Eli Lilly; GlaxoSmithKline; Johnson & Johnson; Merck; Metis; NPS; Ortho-McNeil; Pfizer; Pozen; UCB Pharma; X-Cel Pharmaceuticals; is a scientific advisor for Abbott; Allergan; AstraZeneca; Eli Lilly; GlaxoSmithKline; Johnson & Johnson; Merck; Metis; NPS; OrthoMcNeil; Pfizer; Pozen; UCB Pharma; X-Cel Pharmaceuticals; and is on the product/speaker’s bureaus for Abbott; Allergan; AstraZeneca; Eli Lilly; GlaxoSmithKline; Johnson & Johnson; Merck; Metis; NPS; OrthoMcNeil; Pfizer; Pozen; UCB Pharma; X-Cel Pharmaceuticals.

Suzanne E. Simons, MS, has no relevant financial relationships to disclose.

Philip M. Wakefield, MD, FACOG, is on the product/speaker’s bureaus for Berlex; Forrest; GlaxoSmithKline; Lilly; Pfizer; Pharmacia; Roche; Therex; Warner Chilcott; Wyeth; and is a stock/shareholder of Forrest; Lilly; Pfizer.

Richard G. Wenzel, PharmD, is on the product/speaker’s bureaus for Allergan; GlaxoSmithKline.

Last updated December 15, 2006